Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex FormulationsBusiness Wire • 10/30/24
Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue GrowthZacks Investment Research • 10/24/24
Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call DateBusiness Wire • 10/09/24
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery OfferingsBusiness Wire • 10/08/24
Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness Wire • 08/28/24
Simulations Plus (SLP) Restructures Business Unit Post-AcquisitionsZacks Investment Research • 08/26/24
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic AcquisitionsBusiness Wire • 08/23/24
Simulations Plus to Participate in KeyBanc's 25th Annual Technology Leadership ForumBusiness Wire • 07/25/24
Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics SafetyBusiness Wire • 07/11/24
Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionBenzinga • 07/03/24
Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 06/25/24
Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI SummitBusiness Wire • 06/20/24
Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call DateBusiness Wire • 06/18/24